Shane schaffer cingulate
WebCingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens … WebApr 5, 2024 · Cingulate chairman and CEO Shane Schaffer said: “We’re pleased with the speed in which our first cohort of this Phase III trial was able to be completed, …
Shane schaffer cingulate
Did you know?
Web20 hours ago · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. … WebOct 20, 2024 · Cingulate is headquartered in Kansas City. For more information visit Cingulate.com. Investor Contact: Thomas Dalton Vice President, Investor & Public Relations, Cingulate [email protected] ...
Web20 hours ago · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed … WebApr 14, 2024 · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. …
WebAug 11, 2024 · Aug 11, 2024 Cingulate Inc. Reports Second Quarter 2024 Financial Results and Provides Clinical and Business Update ... (ADHD) and anxiety could benefit from the true once-daily medications we are advancing now,” said Shane J. Schaffer, Cingulate Chairman & CEO. Schaffer continued, “Capital is imperative to any clinical-stage company’s ... WebShane Schaffer . The Cingulate Therapeutics Leadership Team possesses a unique combination of clinical, medical, financial, regulatory and commercial expertise, including: • Extensive pharmaceutical industry experience • 50-years of neuroscience clinical experience • Published over 200 peer-reviewed publications
Web20 hours ago · Cingulate Inc. (NASDAQ: CING), is a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...
WebShane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and has served as the Chairman and CEO since its inception. Dr. Schaffer is an 18-year pharmaceutical industry … mandol medication labelWebPeople named Shane Schaffer. Find your friends on Facebook. Log in or sign up for Facebook to connect with friends, family and people you know. Log In. or. Sign Up. Shane … korea battle simulation center kbscWebShane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and has served as the Chairman and CEO since its inception. Dr. Schaffer is a 25-year pharmaceutical industry … mando marine alternator wiring diagramWeb20 hours ago · Dr. Schaffer will also provide a company overview and recap recent Cingulate clinical and business updates. The event may be viewed live on Benzinga's YouTube channel, Benzinga All Access, and ... mando meaning in englishWebDec 20, 2024 · Shane Schaffer, Chairman & CEO of Cingulate, Inc. CING, was a guest on Benzinga’s All Access on 12/16/22. Cingulate is a clinical-stage biopharmaceutical … korea beauty boxWebMar 14, 2024 · Cingulate chairman and CEO Shane Schaffer said: “This agreement provides a clear path to commercialise CTx-1301, upon FDA approval, designed specifically to … korea beauty cosmeticsWebCingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD BioSpace Shane Schaffer on LinkedIn: Cingulate Initiates … korea basic speaking